Generation Bio Co

NASDAQ GBIO
$5.99 0.21 3.63%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 28.75 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
27.14M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-14.29M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
67.00M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
465.09 %

Upcoming events Generation Bio Co

All events
No upcoming events scheduled

Stock chart Generation Bio Co

Stock analysis Generation Bio Co

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.38 -1.30
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
0.82 1.15
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
0.22 -0.75
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.65 0.42
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-98.09 -50.00

Price change Generation Bio Co per year

0.30$ 6.66$
Min Max

Summary analysis Generation Bio Co

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Generation Bio Co

Revenue and net income Generation Bio Co

All parameters

About company Generation Bio Co

Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle, or ctLNP platform. ctLNP delivery system is designed to address the limitations of existing technologies and comprises three elements. First, LNP from interacting with serum-binding proteins and reduces clearance by the liver and spleen. Second, identify and refine a small format targeting ligand against a receptor uniquely expressed on the target cell to achieve highly potent and selective delivery to specific tissues and cell types of interest. Finally, bioconjugated linkers that facilitate modular attachment of the targeting ligands to the core stealth LNP; and novel immune-quiet DNA (iqDNA) enable long-lasting high levels of gene expression from non-integrating episomes and avoid innate immune sensors that have long prevented DNA from use in non-viral systems. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Address:
301 Binney Street, Cambridge, MA, United States, 02142
Company name: Generation Bio Co
Issuer ticker: GBIO
ISIN: US37148K1007
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2020-06-12
Sector: Healthcare
Industry: Biotechnology
Site: https://generationbio.com